Home > Financial Ratios > AUROBINDO PHARMA

AUROBINDO PHARMA
EBIT Growth

    Back to All Ratios
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) 18.2869.62-19.54-53.8883.25

What is the latest EBIT Growth ratio of AUROBINDO PHARMA ?

The latest EBIT Growth ratio of AUROBINDO PHARMA is 18.28 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar202518.28
Mar202469.62
Mar2023-19.54
Mar2022-53.88
Mar202183.25

How is EBIT Growth of AUROBINDO PHARMA Trending?

Years EBIT Growth % Change
Mar2025 18.28
-73.74
Mar2024 69.62
Positive
Mar2023 -19.54
Negative
Mar2022 -53.88
Negative
Mar2021 83.25 -

Other Financial Ratios of AUROBINDO PHARMA


Compare EBIT Growth ratio of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹81,108.7 Cr 0% 10.9% 13.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹426,830.0 Cr 4.7% -0.3% -3.1% Stock Analytics
DIVIS LABORATORIES ₹173,484.0 Cr 2.3% 6.8% 9.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹143,166.0 Cr 2.5% -1.7% 26.5% Stock Analytics
DR REDDYS LABORATORIES ₹111,018.0 Cr 11.3% 7.6% 12.5% Stock Analytics
CIPLA ₹106,357.0 Cr 5.9% 7.3% -14.1% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

0%

10.9%

13.6%

SENSEX

-1.3%

4.6%

-3.3%


You may also like the below Video Courses